Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why is this Company combining Artificial Intelligence and Psychedelics to address Mental Afflictions

(Click image to play video) Did you know that in Canada, it is estimated that by the age of 40, half of the population will have, or will have had, a mental illness? The recent surge of interest in psychedelic drugs is due to their potential for more effective tr...

Buzz on the Bullboards: They Can Build You Up, They Can Tear You Down

(Drill core from hole NFGC-21-182 via New Found Gold Corp.) “Sell in May and go away” is a common term used by many in the investing world and while that seems true right now, there is a lot happening around all the market sectors that have kep...

“Empowering” a New Revolution in Mind, Body and Health Care

When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...

Auryn Resources, Osino Resources, Scottie Resources - who is the most attractive gold explorer?

This year's Metals Investor Forum will be held on the East Coast in Toronto on February 29 and March 1, 2020. According to the organizers, the goal is to present a selective number of exhibitors with high quality to the participating investors. The event format will also ...

Aphria, Aurora Cannabis, Canopy Growth, EXMceuticals - do not miss the entry!

The German nationwide and anonymous advertising format of Deutsche Post is called POSTAKTUELL and is published regularly in large print runs. The stack of advertising is wrapped in a foil and the practical added value for the recipient is the TV guide. The front of POSTAKTUELL...

E*TRADE, flatex, wallstreet:online: the winners of the Corona Pandemic

Since the beginning of the Corona Pandemic, economic life has tended to shift from the offline to the online world. The winners of this trend are e-commerce service providers, such as Amazon and HelloFresh, and above all the operators of online brokerage platforms. This phenom...

Buzz on the Bullboards: Big Movers in Mining, Industrials, & Cannabis

(Image via Ivanhoe Mines Ltd.) Is cannabis on the verge of a breakout? Which industrial plays are advancing in the market? What is the next resource mining investors are tracking? Does a spike in a market’s collective share price signify an opportu...

Auto industry rebound could drive these under $10 stocks

The unpopular trade I told you about one month ago – to go long homebuilding stocks – is off to a great start. The big homebuilder fund ( XHB ) is up around 8% so far, and just hit a new yearly high. Today, I have another trade most people will think is crazy, whi...

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...
1 2 3 4 5 6 7 8